Drug Pipeline

Efanesoctocog alfa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in…
date change Primary completion pushed: 2026-04-30 -> 2026-05-30
Active Studies by Phase
Phase 4
2
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06940830 Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world… Hemophilia A Recruiting
NCT06752850 A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A… Haemophilia A (Moderate or Severe) Active, Not Recruiting
Phase 3
NCT06716814 Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial… Haemophilia A (Moderate or Severe) Recruiting
Phase 1
NCT06579144 Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in… Hemophilia A Recruiting
Sponsors Running Efanesoctocog alfa Trials
Disease Areas
Get alerts when Efanesoctocog alfa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free